Plasma Septin9 versus Fecal Immunochemical Testing for Colorectal Cancer Screening: A Prospective Multicenter Study
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Plasma Septin9 versus Fecal Immunochemical Testing for Colorectal Cancer Screening: A Prospective Multicenter Study
Authors
Keywords
Colorectal cancer, Colonoscopy, Blood, Cancer screening, Adenomas, Blood plasma, DNA methylation, Ethnicities
Journal
PLoS One
Volume 9, Issue 6, Pages e98238
Publisher
Public Library of Science (PLoS)
Online
2014-06-06
DOI
10.1371/journal.pone.0098238
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evaluating Test Strategies for Colorectal Cancer Screening: A Decision Analysis for the U.S. Preventive Services Task Force
- (2013) Ann G. Zauber et al. ANNALS OF INTERNAL MEDICINE
- Aberrant septin 9 DNA methylation in colorectal cancer is restricted to a single CpG island
- (2013) Reinhold Wasserkort et al. BMC CANCER
- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Prospective evaluation of methylatedSEPT9in plasma for detection of asymptomatic colorectal cancer
- (2013) Timothy Robert Church et al. GUT
- Long-Term Colorectal-Cancer Incidence and Mortality after Lower Endoscopy
- (2013) Reiko Nishihara et al. NEW ENGLAND JOURNAL OF MEDICINE
- Uptake and positive predictive value of fecal occult blood tests: A randomized controlled trial
- (2013) Jessica Chubak et al. PREVENTIVE MEDICINE
- Impact of Screening Colonoscopy on Outcomes in Colon Cancer Surgery
- (2013) Ramzi Amri et al. JAMA Surgery
- New insights into cervical cancer screening
- (2012) Jonathan D. Boone et al. Journal of Gynecologic Oncology
- Detection of Methylated SEPT9 in Plasma Is a Reliable Screening Method for Both Left- and Right-Sided Colon Cancers
- (2012) Kinga Tóth et al. PLoS One
- A Tissue-Based Comparative Effectiveness Analysis of Biomarkers for Early Detection of Colorectal Tumors
- (2012) Deeqa Ahmed et al. Clinical and Translational Gastroenterology
- Septin roles in tumorigenesis
- (2011) Diana Connolly et al. BIOLOGICAL CHEMISTRY
- Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer
- (2011) Jorja D Warren et al. BMC Medicine
- Adverse events after screening and follow-up colonoscopy
- (2011) Carolyn M. Rutter et al. CANCER CAUSES & CONTROL
- Factors Influencing Colorectal Cancer Screening Participation
- (2011) Antonio Z. Gimeno García Gastroenterology Research and Practice
- From discovery to the clinic: the novel DNA methylation biomarkermSEPT9 for the detection of colorectal cancer in blood
- (2010) Shannon R Payne Epigenomics
- Circulating Methylated SEPT9 DNA in Plasma Is a Biomarker for Colorectal Cancer
- (2009) T. deVos et al. CLINICAL CHEMISTRY
- Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline From the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology
- (2008) Bernard Levin et al. GASTROENTEROLOGY
- Sensitive Detection of Colorectal Cancer in Peripheral Blood by Septin 9 DNA Methylation Assay
- (2008) Robert Grützmann et al. PLoS One
- DNA Methylation Biomarkers for Blood-Based Colorectal Cancer Screening
- (2007) C. Lofton-Day et al. CLINICAL CHEMISTRY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started